Take a look at these startling
results from studies from around the world:
To support her claims, she mentioned
the results from a study from October to December of 2014 that showed 44 percent of early adopters said an interesting bread or bun would get them to try a new item.
Not exact matches
While the new mid-stage
study results from DNDi were impressive (they showed cure rates of 96 % to 97 % even for the sickest patients and those with liver scarring), more late - stage trials will be necessary before the drug is available on a large scale in the developing world.
The third
study looked at
results from online commitment contract service StickK to see when aspirational behaviour spiked.
During the question period it was clear that the
results from Madsen's
study didn't take into consideration whether some family members involved with the business could have been
studying or working abroad.
Also, as data was only collected over a few months, it's unclear whether this was a one time «pop» in aggressiveness that
resulted from study subjects being worked up about the election, or whether the change in negotiating tactics will hold steady.
But if these
results from an admittedly small
study hold up, and your mainly concerned with maximizing shuteye, you should probably also consider penning a to - do list before bed.
And in regards to the role that color plays in branding,
results from studies such as The Interactive Effects of Colors show that the relationship between brands and color hinges on the perceived appropriateness of the color being used for the particular brand (in other words, does the color «fit» what is being sold).
But it's important to note that these
results were
from observational
studies of healthy adults, and there could still be plenty of confounding factors that lead to dementia.
Here's the most revealing finding
from the Achievement Group / HRmarketer
study: 58 percent of respondents agreed that
results did not — or only slightly — helped managers gain a better understanding of what behaviors or practices they could change to improve.
This infographic
from Walker Sands shares
results from its 2014
study on the Future of Retail, featuring insights on a number of issues, including the impact of free shipping and what shoppers won't buy
from Amazon, the online retail giant.
Though the
study's
results were self - reported and were for just one country, in a statement
from the University, Schou Andreassen said, «taking work to the extreme may be a sign of deeper psychological or emotional issues.
The plan is to
study the
results from the first year and share everything they learn.
The
study found that
results from Theranos differed
from those of Quest Diagnostics and LabCorp, the other two labs in the
study.
A
study in the British Medical Journal suggests that if you're over 50, the best
results come
from combining aerobic and resistance exercise, which could include anything
from high - intensity interval training, like the seven - minute workout, to dynamic - flow yoga, which intersperses strength - building poses like planks and push - ups with heart - pumping dance - like moves.
BIIB098: MRI and relapse
results from the phase 3 EVOLVE - MS - 1
study in patients with relapsing and remitting multiple sclerosis were presented at the 70th annual meeting of the American Academy of Neurology (AAN).
That's a far cry
from the
results of a
study commissioned this year by the Freelancers Union and Elance - oDesk, which put the number of freelancers — a broader category that includes temps, part - timers, and moonlighters — at 53 million, or one in three American workers.
Results from the UPenn
study are expected this spring.
The end
result of this benchmarking was a salary arms race: between 1936 and 1980, the average CEO salary increased
from $ 970,000 to $ 1.1 - million, according to a 2010
study.
Airbnb in its
study projects a loss of $ 405 million over the next 10 years
from the pockets of San Francisco Airbnb hosts who would lose rental income as a
result of the proposed limit, according to Nulty.
This year's new offering: dog beds that, according to Casper's website,
resulted from 11 months of dog sleep
studies.
Actual
results and the timing of events could differ materially
from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and
studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.
Yes, the
study is
from Hewlett Packard, but still the
results are eye - opening: Nearly every small business surveyed (93 percent) admitted they tried to save money instead of buying what they really wanted.
BMO said
results of the
study were compiled
from a Pollara telephone survey of 301 Canadian business owners between Aug. 22 and Sept. 10.
These
results echo a recent Gallup
study showing that employees who work
from home three to four days a week are far more likely (41 percent versus 30 percent) to «feel engaged» and far less likely (48 percent versus 55 percent) to feel «not engaged» than people who report to the office each day.
Instead of just focusing on human DNA, which in the other
studies had yielded limited
results, she looked at multiple sets of genes — and not just
from humans.
These
results are also consistent with a stack of
studies showing all sorts of behavior,
from laughter to productivity, are also catching.
Team
results were also
studied so a player would benefit
from victories but would be punished for losses, regardless of his own individual performance.
Bachelder's story, documented in her book, Dare to Serve: How to Drive Superior
Results by Serving Others, is the most compelling case
study to showcase the power of servant leadership to reinvent a company
from the inside out.
Alexion Reports First Quarter 2018
Results and Positive Topline Data
from ALXN1210 Phase 3 PNH Switch
Study
It's possible that the 2012
results differ
from Meer's because the prior
study focused on gifts sent after a donation is received.
In parallel, adjudication will be completed for all MACE which occurred during the
study, including adjudication for certain events which, per protocol, can not be finally adjudicated until patients complete their final site visit and
results are available
from certain non-invasive diagnostic testing conducted during such site visits.
Gicheva conducted the
study using GMAT Registrant Survey
results, which were collected over the course of seven years
from almost 2,000 U.S. workers.
The company believes that it is on track to achieve its objective of reporting top - line
results from this important
study before the end of Q3 2018.
Recommendations
from friends are among the top influences of purchases, according to a recent
study by ForeSee
Results, a market research firm in Ann Arbor, Michigan.
We are pleased that increasing numbers of physicians are prescribing Vascepa to help their patients and we are confident that the
results from the REDUCE - IT
study will lead to better informed decisions regarding patient care.»
Detailed 48 - week
results from a Phase 3
study evaluating the efficacy and safety of switching
from a regimen containing abacavir, dolutegravir and lamivudine (600 / 50/300 mg)(ABC / DTG / 3TC) to Biktarvy, a once - daily single tablet regimen, in virologically suppressed adults with HIV.
71 % of respondents in the Virgin Pulse
study indicated that they eat unhealthily
from two to five days a week as a
result of the holidays.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial
results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable
results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data
from clinical
studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified
from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Results from a preclinical
study conducted in collaboration with researchers at Beth Israel Deaconess Medical Center evaluating the combination of a proprietary investigational oral toll - like receptor 7 agonist, GS - 9620, and a proprietary investigational broadly neutralizing antibody, as part of an HIV eradication strategy.
Buxton says the
study's
results point to a need for a culture shift in organizations toward a provision for greater flexibility and a change in mentality
from a focus on congratulating those who burn the candle at both ends to an appreciation of the benefits of sleep.
First, in 2009 there was an increase in federal tobacco tax.35 The national cigarette tax increased by 158 %,
resulting in an immediate reduction in cigarette uptake among US adolescents.35 In our
study we found a small but statistically significant increase in quit attempts among US adults,
from 39.9 % in 2006 - 07 to 41.4 % in 2010 - 11 (fig 2, top panel).
A survey of New York City employers after implementation of the city's paid sick days law showed that more than 91 percent of respondents did not reduce hiring; 97 percent did not reduce hours; and 94 percent did not raise prices as a
result of the law.26 In a similar
study from Connecticut, which passed a statewide paid sick days law in 2011, employers also reported no effects or modest effects to their bottom lines.27 And an audit of the District of Columbia's paid sick leave law, effective in 2008, found that it did not discourage business owners
from basing their businesses in the District, nor did it incentivize them to relocate their businesses outside of Washington.28
In looking at case
studies across industries and channels,
from email to web to location - based marketing, it produces amazing
results.
To date,
results from several longitudinal
studies indicate that e-cigarette use among nonsmoking youth increases the likelihood of future use of conventional cigarettes.5 — 10 Specifically, the pooled odds ratio (OR) in a recent meta - analysis of
studies of adolescents and young adults (aged 14 — 30) indicates that those who had ever used e-cigarettes were 3.62 times more likely to report using cigarettes at follow - up compared with those who had not used e - cigarettes.11 This finding was robust and remained significant when adjusting for known risk factors associated with cigarette smoking, including demographic, psychosocial, and behavioral variables such as cigarette susceptibility.
«Based on the
results from these Phase 3
studies, the combination of bictegravir and FTC / TAF could represent an important advance in triple - therapy treatment for a broad range of HIV patients, and we look forward to submitting regulatory applications in the U.S. and EU this year.»
This
study estimates the costs to steel consumers and others of steel quotas or taxes that could
result from a Section 201 investigation or legislation pending before Congress.
A
study of the
results of separating the chair and CEO roles in Swiss companies by professors Markus M. Schmid and Heinz Zimmermann
from the University of Basel reached similar conclusions: «We find no evidence of a systematic and significant difference in valuation between firms with combined and firms with separated functions.»
Accordingly, what the Commission properly can infer
from these data is limited and, in any event, other
studies show competing
results.
That's why, when Biogen shared initial positive
results from an early
study in December, the stock jumped 6 percent — and has continued climbing, up 39 percent since Dec. 1, compared with a 19 percent gain for the Nasdaq biotechnology index.